Isabella Ciccone, Associate Editor, NeurologyLive®, has been with the team since September 2022. Follow her on Twitter @iciccone7 or email her at iciccone@mjhlifesciences.com
Galcanezumab Shows Greatest Reduction in Disease Burden Following Switching
June 21st 2023Following the initiation or switch to a new migraine preventive medication, patients taking galcanezumab showed numerically greater 3-month improvements for most measures of health-related quality of life and disability.
Intravenous Ketamine Significantly Reduces Pain in Refractory Pediatric Headache
June 19th 2023The use of intravenous ketamine in pediatric patients with refractory headaches resulted in a median pain reduction of 50% at discharge and nearly two-third of patients did not need further rescue therapies 1 month posttreatment.
Behavioral Strategies for Management and Destigmatizing Migraine
June 17th 2023Elizabeth K. Seng, PhD, associate professor at Yeshiva University and Albert Einstein College of Medicine, talked about migraine management through the lens of behavioral factors that clinicians can recommend and encourage to their patients.
Migraine Related Stigma and its Impact on Patients in Healthcare
June 17th 2023Allison Verhaak, PhD, a clinical psychologist from Ayer Neuroscience Institute at Hartford Healthcare Headache Center, discussed focus group and survey data on themes in migraine-related stigma, and the importance of creating a migraine specific stigma scale.
Contraindicated Medication Use Significantly Impacts Length of Hospitalization in Parkinson Disease
June 14th 2023Patients with Parkinson disease who were inpatients had significant impacts on their length of stay, readmissions, and morbidity after hospitalization when administered contraindicated medications.
Samelisant Shows Potential as a Treatment for Excessive Daytime Sleepiness in Parkinson Disease
June 7th 2023Preclinical findings show the potential of samelisant, a potent and orally active Histamine H3 receptor inverse agonist, as a potential treatment for patients with Parkinson disease who experience excessive daytime sleepiness.
Effectiveness of Mindfulness-Based Interventions to Reduce Stress in Patients With MS
June 5th 2023At the 2023 CMSC Annual Meeting, Christopher C. Hemond, MD, assistant professor of neurology at UMass Chan Medical School, provided an overview of his study on mindfulness-based stress reduction in patients with MS using MRI and patient outcomes.